BD Board Declares Dividend
BD (NYSE: BDX), a leading global medical technology company, has announced its quarterly dividend declaration. The Board of Directors has declared a quarterly dividend of $1.04 per common share. The dividend will be paid on September 30, 2025, to shareholders of record as of September 8, 2025. Based on this quarterly payout, the indicated annual dividend rate stands at $4.16 per share.
BD (NYSE: BDX), un'azienda leader mondiale nella tecnologia medica, ha annunciato la dichiarazione del dividendo trimestrale. Il Consiglio di Amministrazione ha dichiarato un dividendo trimestrale di 1,04 $ per azione ordinaria. Il dividendo sarà pagato il 30 settembre 2025 agli azionisti registrati al 8 settembre 2025. In base a questo pagamento trimestrale, il tasso annuale del dividendo indicato è di 4,16 $ per azione.
BD (NYSE: BDX), una empresa líder mundial en tecnología médica, ha anunciado su declaración de dividendo trimestral. La Junta Directiva ha declarado un dividendo trimestral de 1,04 $ por acción común. El dividendo se pagará el 30 de septiembre de 2025 a los accionistas registrados al 8 de septiembre de 2025. Basado en este pago trimestral, la tasa anual de dividendo indicada es de 4,16 $ por acción.
BD (NYSE: BDX), 세계적인 의료 기술 선도 기업이 분기 배당금을 발표했습니다. 이사회는 보통주 1주당 1.04달러의 분기 배당금을 선언했습니다. 배당금은 2025년 9월 30일에 지급되며, 기록 기준일은 2025년 9월 8일입니다. 이 분기 배당을 기준으로 연간 배당률은 주당 4.16달러입니다.
BD (NYSE : BDX), une entreprise mondiale de premier plan dans le domaine de la technologie médicale, a annoncé la déclaration de son dividende trimestriel. Le conseil d'administration a déclaré un dividende trimestriel de 1,04 $ par action ordinaire. Le dividende sera versé le 30 septembre 2025 aux actionnaires inscrits au 8 septembre 2025. Sur la base de ce paiement trimestriel, le taux de dividende annuel indiqué s'élève à 4,16 $ par action.
BD (NYSE: BDX), ein weltweit führendes Medizintechnikunternehmen, hat seine Quartalsdividende bekanntgegeben. Der Vorstand hat eine Quartalsdividende von 1,04 $ je Stammaktie beschlossen. Die Dividende wird am 30. September 2025 an die zum 8. September 2025 eingetragenen Aktionäre ausgezahlt. Basierend auf dieser Quartalszahlung beträgt die angegebene jährliche Dividendenrate 4,16 $ pro Aktie.
- Consistent dividend payment demonstrates financial stability
- Annual dividend rate of $4.16 per share provides steady income for shareholders
- None.
About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/, X (formerly Twitter) @BDandCo or Instagram @becton_dickinson.
Contacts:
Media: | Investors: |
Troy Kirkpatrick | Adam Reiffe |
VP, Public Relations | Sr. Director, Investor Relations |
858.617.2361 | 201.847.6927 |
View original content:https://www.prnewswire.com/news-releases/bd-board-declares-dividend-302511017.html
SOURCE BD (Becton, Dickinson and Company)